Formoterol Fumarate Solution
Product Images NDC 0093-4061

9 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Formoterol Fumarate (NDC 0093-4061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

1 (Image 1)
Chemical structure of formoterol fumarate dihydrate showing two formoterol molecules and one fumaric acid molecule with dihydrate (two water molecules) indicated.*
FDA Label Image

1 (Image 2)

1 (Image 2)
A line graph comparing mean FEV1 (in liters) over time (hours) between Formoterol fumarate 20 mcg and placebo. The graph shows data points from 0 to 12 hours, with Formoterol fumarate maintaining higher mean FEV1 values throughout the period compared to placebo.*
FDA Label Image

1 (Image 3)

1 (Image 3)
A line graph comparing mean FEV1 in liters over 12 hours between Formoterol Fumarate 20 mcg and placebo groups. The x-axis represents time in hours and the y-axis shows mean FEV1 values. Two lines illustrate the respiratory function difference, one for Formoterol Fumarate and one for placebo.*
FDA Label Image

1 (Image 4)

1 (Image 4)
An instructional illustration showing hands preparing a respiratory inhalation device. One hand holds the inhaler mouthpiece, while the other hand inserts or taps a small component into the inhaler base, indicating assembly or priming before use.*
FDA Label Image

1 (Image 5)

1 (Image 5)
Illustration showing hands holding a respiratory inhalation device and a separate component, likely depicting how to assemble or use the Formoterol fumarate inhalation solution device.*
FDA Label Image

1 (Image 6)

1 (Image 6)
An instructional illustration showing a person using a respiratory inhalation device, placing the mouthpiece in their mouth and activating the device with one hand. This likely demonstrates how to administer Formoterol fumarate solution via inhalation.*
FDA Label Image

1 (Image 7)

1 (Image 7)
An instructional illustration showing a person using a respiratory inhalation device with a face mask. The person holds the inhaler in one hand and places the mask over the nose and mouth, demonstrating proper use of the inhalation solution device.*
FDA Label Image

1 (Image 8)

1 (Image 8)
Packaging label for Formoterol Fumarate Inhalation Solution 20 mcg/2 mL vial by Teva Pharmaceuticals USA, Inc. The label indicates a package containing 30 individually wrapped 2 mL sterile unit dose vials for oral inhalation. The label includes active and inactive ingredient information and states it is for prescription use only.*
FDA Label Image

1 (Image 9)

1 (Image 9)
Packaging label for Formoterol Fumarate Inhalation Solution 20 mcg/2 mL vial by Teva Pharmaceuticals USA, Inc. The label states it contains sterile unit dose vials, individually wrapped, with 60 vials per package. It includes active and inactive ingredients, usage instructions, and NDC 0093-4061-06. The Teva logo appears in green on a white background with a subtle green curve design.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.